A carregar...
Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma
Glioblastoma multiforme (GBM) is the most aggressive and common primary central nervous system tumour. Despite extensive therapy, GBM patients usually have poor prognosis with a median survival of 12–15 months. Novel molecular biomarkers that can improve survival prediction and help with treatment s...
Na minha lista:
| Publicado no: | Mol Neurobiol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541357/ https://ncbi.nlm.nih.gov/pubmed/32875483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-020-02088-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|